RxSight, Inc.
RXST
$13.53
$0.221.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.19M | -5.94M | -6.34M | -6.08M | -9.10M |
| Total Depreciation and Amortization | 785.00K | 523.00K | 1.14M | 820.00K | 1.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.78M | 4.73M | 3.98M | 4.09M | 3.30M |
| Change in Net Operating Assets | -6.21M | -3.57M | 1.87M | -2.86M | -4.65M |
| Cash from Operations | -8.83M | -4.26M | 650.00K | -4.03M | -9.31M |
| Capital Expenditure | -575.00K | -847.00K | -1.10M | -1.52M | -1.97M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.43M | 2.17M | -8.16M | -114.12M | 26.24M |
| Cash from Investing | 20.86M | 1.32M | -9.26M | -115.65M | 24.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.00K | -12.00K | -11.00K | -11.00K | -27.00K |
| Issuance of Common Stock | 696.00K | 2.99M | 3.84M | 111.94M | 10.15M |
| Repurchase of Common Stock | -1.42M | 0.00 | -2.64M | -- | -2.13M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -311.00K | -457.00K | -- |
| Cash from Financing | -735.00K | 2.98M | 878.00K | 111.47M | 7.99M |
| Foreign Exchange rate Adjustments | 6.00K | -12.00K | 7.00K | -1.00K | -3.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.29M | 24.00K | -7.73M | -8.20M | 22.95M |